Lakefront Biotherapeutics(DE:GXEA)
€31.20-0.20 (-0.64%)
DE:GXEA
Lakefront Biotherapeutics earnings date
€31.20
At close:-0.20 (-0.64%)
Lakefront Biotherapeutics (GXEA) Q1 2023 Earnings Report
1 Followers
DE:GXEA Q1 2023 EPS Results
- Actual EPS
- EUR 0.35
- Consensus EPS
- -EUR 0.87
- Beat/Miss
- Beat by +EUR 1.22
- One Year Ago EPS
- -EUR 0.19
DE:GXEA Q1 2023 Revenue Results
- Actual Revenue
- EUR 174.11M
- Expected Revenue
- EUR 99.50M
- Beat/Miss
- Beat by +EUR 74.62M
- YoY Revenue Growth
- +25.47%
Earnings Announcement Details
- Quarter
- Q1 2023
- Date
- 05/04/2023
- Time
- After Close
- Conference Call
- Thursday, May 4, 2023
DE:GXEA Upcoming Earnings
Lakefront Biotherapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q1 2023 Earnings Call Audio
DE:GXEA Q1 2023 Earnings Call
0:00 / 0:00
Q1 2023 Earnings Slide Deck
Q1 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GXEA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | -0.63- | 12.61 | ― | ― |
| Nov 11, 2026 | 2026 (Q3) | -0.33-0.04 | -3.21 | 98.76% (+3.17) | |
| Aug 10, 2026 | 2026 (Q2) | -0.750.03 | -1.68 | 101.83% (+1.71) | |
| May 06, 2026 | 2026 (Q1) | -0.860.22 | -2.43 | 109.24% (+2.65) | |
| Feb 23, 2026 | 2025 (Q4) | ―12.61 | 0.27 | 4502.65% (+12.34) | |
| Nov 05, 2025 | 2025 (Q3) | -0.43-3.21 | -0.73 | -341.22% (-2.49) | |
| Jul 23, 2025 | 2025 (Q2) | -0.21-1.68 | 0.07 | -2475.64% (-1.75) | |
| Apr 23, 2025 | 2025 (Q1) | -0.13-2.43 | 0.35 | -788.92% (-2.78) | |
| Feb 12, 2025 | 2024 (Q4) | -0.500.27 | 2.35 | -88.32% (-2.07) | |
| Oct 30, 2024 | 2024 (Q3) | -0.15-0.73 | 0.38 | -291.65% (-1.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


